ISPE

JULY 28, 2023

Message from the Chair: Why Attend the 2023 ISPE Pharma 4.0™ ™ & Annex 1 Conference Trudy Patterson Fri, 07/28/2023 - 10:40 iSpeak Blog iSpeak Message from the Chair: Why Attend the 2023 ISPE Pharma 4.0™ Message from the Chair: Why Attend the 2023 ISPE Pharma 4.0™

96

96

ISPE

JULY 28, 2023

Message from the Chair: Why Attend the 2023 ISPE Pharma 4.0™ ™ & Aseptic Conference Trudy Patterson Fri, 07/28/2023 - 10:40 iSpeak Blog iSpeak Message from the Chair: Why Attend the 2023 ISPE Pharma 4.0™ ™ and Annex 1 Conference in Manchester back in 2019, I was surprised by how few people I knew.

98

98

ISPE

MARCH 16, 2023

The major trends in the recent years are (1) fully automated production such as continuous manufacturing and (2) the adoption of digitalized processes for paperless production. We will also address the ways in which these approaches can help to improve adherence to new Annex 1 and the overall quality and safety of pharmaceutical products.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Documentation Dosage 98

ISPE

MARCH 8, 2023

1 UK Medicines and Healthcare Products Regulatory Agency. “A The number and breakdown by contaminants/impurities are provided in Table 1. 11 Table 1: Contamination-associated recalls from 2017 to 2021. Reports of contaminated products from multiple sources worldwide were gathered to review overall trends and identify challenges.

Compounding 52

Compounding Compounding Pharmacies Packaging FDA 52